Validation Tools & Test Sites

Schematron Validator

The Lantana Group provides a Schematron Validator that can be used to validate CDAs in an effective and efficient way. The Schematron Validator tests XML files for compliance to the CDA Release 2 (R2) standard, as well as the data constraints imposed by the Implementation Guide.  However, the Schematron Validator does not test the data for NHSN rules outlined in the NHSN Protocol documents.  These rules are described in the Implementation Toolkit and can only be validated by submitting your CDA documents directly to NHSN through a test facility.

The Lantana Group’s Schematron ValidatorExternal

When validating a CDA file within the Lantana Group’s Schematron Validator, select the specific HAI Implementation Guide the CDA file is based on.

When validating a CDA file within the Lantana Group’s Schematron Validator, select the specific HAI Implementation Guide the CDA file is based on


Pre-Production Test Site (NPPT)

The purpose of the NHSN Pre-Production Test Site is to allow CDA Vendors and facilities creating CDAs in-house the ability to test new CDAs prior to each NHSN production release. This will allow Vendors and CDA Facilities to perform their quality assurance (QA) earlier and roll out the new CDA versions earlier.

Please complete the form below and send the completed form to the nhsncda@cdc.gov mailbox.

You will then receive an email with detailed instructions and login information for accessing the Pre-Production Test Site.

NHSN Pre-Production Site Enrollment form Cdc-word[DOCX – 23K]

 

Production Test Site

The purpose of an NHSN Production Test Site is to allow CDA implementers the ability to test CDAs in the active NHSN environment to support customers and troubleshoot issues. CDA vendors or organizations that have the capability to develop and implement CDA with their internal resources may request a test facility in the NHSN production environment. The production environment does require Secure Access Management Services (SAMS) credentials for all individual users. Users must be a US citizen and have a US mailing address to complete the SAMS process.

If interested, please send an email to the nhsncda@cdc.gov mailbox requesting a CDA test facility in the production environment.

 Top of Page